DIGN First North Stockholm
Read more about Dignitana's share at Nasdaq OMX FIRST NORTH
Slide background
Slide background

Company Description

Dignitana operates in the field of medical technology. Dignitana has developed a patented medical cooling system, the DigniCap® System, that reduces the risk of chemotherapy-induced hair loss.

The DigniCap® System plays a significant role in promoting patient well being in an extremely difficult situation. It helps to foster a positive self-image – a factor that has proven to be significant in combination with measures to optimize quality of life and promote an active lifestyle.

In the field of oncology, the DigniCap® System is an established market leader and the de facto standard in the world when it comes to scalp cooling to prevent chemotherapy-induced hair loss. Dignitana is working to develop its existing DigniCap® System to expand its usage into additional areas and is also working to develop products related to the DigniCap® System.